Autoimmune encephalopathy

Seminars in Neurology

Volumn 31, Issue 2, 2011, Pages 144-157

  Flanagan, Eoin P ^a   Caselli, Richard J ^b  

^a MAYO CLINIC   (United States)

^b MAYO CLINIC   (United States)

Author keywords

Autoimmune; dementia; encephalopathy; steroid responsive; vasculitis

Indexed keywords

AUTOANTIBODY; AZATHIOPRINE; CHOLINERGIC RECEPTOR ANTIBODY; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; INFLIXIMAB; MESNA; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; PREDNISONE; RITUXIMAB; STEROID; TACROLIMUS; VOLTAGE GATED POTASSIUM CHANNEL;

ADD ON THERAPY; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNE ENCEPHALOPATHY; AUTOIMMUNITY; BRAIN BIOPSY; BRAIN DISEASE; BRAIN REGION; CANCER DIAGNOSIS; CELL INFILTRATION; CEREBROSPINAL FLUID ANALYSIS; CLINICAL FEATURE; COGNITIVE DEFECT; CUSHINGOID SYNDROME; DEMENTIA; DEMOGRAPHY; DIABETES MELLITUS; DIAGNOSTIC TEST; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; DRUG DOSE REDUCTION; DRUG MEGADOSE; DRUG WITHDRAWAL; ELECTROENCEPHALOGRAM; ELECTROLYTE DISTURBANCE; FATALITY; HEMORRHAGIC CYSTITIS; HUMAN; HYPERGLYCEMIA; IMMUNOASSAY; IMMUNOTHERAPY; INFECTION; INFLAMMATION; LABORATORY TEST; LYMPHOMA; MENINX; METABOLIC ENCEPHALOPATHY; NEUROIMAGING; NEUROPATHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOPOROSIS; PARANEOPLASTIC ENCEPHALOPATHY; PARANEOPLASTIC NEUROPATHY; PRIORITY JOURNAL; PROGNOSIS; PSYCHOSIS; SARCOIDOSIS; SEROLOGY; SINGLE DRUG DOSE; STEROID THERAPY; SYMPTOM; TREATMENT RESPONSE; VASCULITIS;

ADRENAL CORTEX HORMONES; ANIMALS; AUTOIMMUNE DISEASES OF THE NERVOUS SYSTEM; DEMENTIA; ENCEPHALITIS; HUMANS; THYROIDITIS, AUTOIMMUNE; VASCULITIS, CENTRAL NERVOUS SYSTEM;

EID: 79956226360     PISSN: 02718235     EISSN: 10989021     Source Type: Journal    
DOI: 10.1055/s-0031-1277985     Document Type: Article

References (41)

1. Brain L, Jellinek E H., Ball K. Hashimoto's disease and encephalopathy. Lancet 1966 2 7462 512-514
2. Chong J Y., Rowland L P., Utiger R D. Hashimoto encephalopathy: syndrome or myth? Arch Neurol 2003 60 2 164-171
3. Schott J M., Warren J D., Rossor M N. The uncertain nosology of Hashimoto encephalopathy. Arch Neurol 2003 60 12 1812 author reply 1812
4. Castillo P, Woodruff B, Caselli R et al. Steroid-responsive encephalopathy associated with autoimmune thyroiditis. Arch Neurol 2006 63 2 197-202 (Pubitemid 43261730)
5. Caselli R J., Boeve B F., Scheithauer B W., O'Duffy J D., Hunder G G. Nonvasculitic autoimmune inflammatory meningoencephalitis (NAIM): a reversible form of encephalopathy. Neurology 1999 53 7 1579-1581 (Pubitemid 29491958)
6. Irani S R., Alexander S, Waters P et al. Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan's syndrome and acquired neuromyotonia. Brain 2010 133 9 2734-2748
7. Vincent A, Buckley C, Schott J M. et al. Potassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis. Brain 2004 127 Pt 3 701-712 (Pubitemid 38295483)
8. Lai M, Huijbers M G., Lancaster E et al. Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: a case series. Lancet Neurol 2010 9 8 776-785
9. Flanagan E P., McKeon A, Lennon V A. et al. Autoimmune dementia: clinical course and predictors of immunotherapy response. Mayo Clin Proc 2010 85 10 881-897
10. Lyons M K., Caselli R J., Parisi J E. Nonvasculitic autoimmune inflammatory meningoencephalitis as a cause of potentially reversible dementia: report of 4 cases. J Neurosurg 2008 108 5 1024-1027 (Pubitemid 351656855)
11. Johnson N, Henry C, Fessler A J., Dalmau J. Anti-NMDA receptor encephalitis causing prolonged nonconvulsive status epilepticus. Neurology 2010 75 16 1480-1482
12. Geschwind M D., Tan K M., Lennon V A. et al. Voltage-gated potassium channel autoimmunity mimicking Creutzfeldt-Jakob disease. Arch Neurol 2008 65 10 1341-1346
13. Duffey P, Yee S, Reid I N., Bridges L R. Hashimoto's encephalopathy: postmortem findings after fatal status epilepticus. Neurology 2003 61 8 1124-1126 (Pubitemid 37461950)
14. Dalmau J, Gleichman A J., Hughes E G. et al. Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol 2008 7 12 1091-1098
15. Hoffman Snyder C, Mishark K J., Caviness J N., Drazkowski J F., Caselli R J. Nonvasculitic autoimmune inflammatory meningoencephalitis imitating Creutzfeldt-Jakob disease. Arch Neurol 2006 63 5 766-768
16. McKeon A, Marnane M, O'Connell M, Stack J P., Kelly P J., Lynch T. Potassium channel antibody associated encephalopathy presenting with a frontotemporal dementia like syndrome. Arch Neurol 2007 64 10 1528-1530 (Pubitemid 47572680)
17. Eng J A., Frosch M P., Choi K, Rebeck G W., Greenberg S M. Clinical manifestations of cerebral amyloid angiopathy-related inflammation. Ann Neurol 2004 55 2 250-256 (Pubitemid 38167002)
18. Vernino S, Geschwind M, Boeve B. Autoimmune encephalopathies. Neurologist 2007 13 3 140-147 (Pubitemid 46743081)
19. Hussain N S., Rumbaugh J, Kerr D, Nath A, Hillis A E. Effects of prednisone and plasma exchange on cognitive impairment in Hashimoto encephalopathy. Neurology 2005 64 1 165-166 (Pubitemid 40082963)
20. McKeon A, Lennon V A., Pittock S J. Immunotherapy-responsive dementias and encephalopathies. Continuum Lifelong Learning Neurol 2010 16 2 80-101
21. Lai M, Hughes E G., Peng X et al. AMPA receptor antibodies in limbic encephalitis alter synaptic receptor location. Ann Neurol 2009 65 4 424-434
22. Lancaster E, Lai M, Peng X et al. Antibodies to the GABA(B) receptor in limbic encephalitis with seizures: case series and characterisation of the antigen. Lancet Neurol 2010 9 1 67-76
23. Dalmau J, T?z?n E, Wu H Y. et al. Paraneoplastic anti-N-methyl-D- aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol 2007 61 1 25-36 (Pubitemid 46214241)
24. Calabrese L H., Duna G F., Lie J T. Vasculitis in the central nervous system. Arthritis Rheum 1997 40 7 1189-1201 (Pubitemid 27430129)
25. Salvarani C, Brown R D. Jr, Calamia K T. et al. Primary central nervous system vasculitis: analysis of 101 patients. Ann Neurol 2007 62 5 442-451 (Pubitemid 350308768)
26. Lie J T. Classification and histopathologic spectrum of central nervous system vasculitis. Neurol Clin 1997 15 4 805-819 (Pubitemid 28009349)
27. Lie J T. Primary (granulomatous) angiitis of the central nervous system: a clinicopathologic analysis of 15 new cases and a review of the literature. Hum Pathol 1992 23 2 164-171
28. Caselli R J., Hunder G G., Whisnant J P. Neurologic disease in biopsy-proven giant cell (temporal) arteritis. Neurology 1988 38 3 352-359 (Pubitemid 18083666)
29. Salvarani C, Giannini C, Miller D V., Hunder G. Giant cell arteritis: Involvement of intracranial arteries. Arthritis Rheum 2006 55 6 985-989 (Pubitemid 44917477)
30. Kerr G S., Hallahan C W., Giordano J et al. Takayasu arteritis. Ann Intern Med 1994 120 11 919-929 (Pubitemid 24179154)
31. Hata A, Noda M, Moriwaki R, Numano F. Angiographic findings of Takayasu arteritis: new classification. Int J Cardiol 1996 54 Suppl S155-S163
32. Soliotis F C., Mavragani C P., Moutsopoulos H M. Central nervous system involvement in Sjogren's syndrome. Ann Rheum Dis 2004 63 6 616-620 (Pubitemid 38658387)
33. Kidd D, Steuer A, Denman A M., Rudge P. Neurological complications in Beh?et's syndrome. Brain 1999 122 Pt 11 2183-2194
34. Lucchinetti C F., Gavrilova R H., Metz I et al. Clinical and radiographic spectrum of pathologically confirmed tumefactive multiple sclerosis. Brain 2008 131 Pt 7 1759-1775 (Pubitemid 351957454)
35. Geurts J J., Bö L, Roosendaal S D. et al. Extensive hippocampal demyelination in multiple sclerosis. J Neuropathol Exp Neurol 2007 66 9 819-827 (Pubitemid 47360957)
36. Bunyan R, Popescu B, Carter J et al. Childhood onset multiple sclerosis with progressive dementia and pathological cortical demyelination. Arch Neurol 2011 68 4 525-528
37. Leavitt J A., Campbell R J. Cost-effectiveness in the diagnosis of sarcoidosis: the conjunctival biopsy. Eye (Lond) 1998 12 Pt 6 959-962 (Pubitemid 29027037)
38. Moravan M, Segal B M. Treatment of CNS sarcoidosis with infliximab and mycophenolate mofetil. Neurology 2009 72 4 337-340
39. Cools J, DeAngelo D J., Gotlib J et al. A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome. N Engl J Med 2003 348 13 1201-1214 (Pubitemid 36359296)
40. Ogbogu P U., Bochner B S., Butterfield J H. et al. Hypereosinophilic syndrome: a multicenter, retrospective analysis of clinical characteristics and response to therapy. J Allergy Clin Immunol 2009 124 6 1319-1325 e3
41. Bartynski W S. Posterior reversible encephalopathy syndrome, part 1: fundamental imaging and clinical features. AJNR Am J Neuroradiol 2008 29 6 1036-1042 (Pubitemid 351954863)